pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
(pramipexol + ondansetron)
(pramipexol + ondansetron [INN])
Treatment Resistant Depression
$ANROAlto Neuroscience, Inc.
0 catalysts
Marketed
(prednisolone sodium phosphate + sulfacetamide sodium)
Sulfacetamide Sodium + Prednisolone Sodium Phosphate ((prednisolone sodium phosphate + sulfacetamide sodium))
Anterior Uveitis
Bausch Health US LLC
0 catalysts
Phase 2
(prednisone + valproate sodium)
(prednisone [INN] + valproate sodium)
Diffuse Large B-Cell Lymphoma
Respiratorius AB
0 catalysts
← prev
page 45 of 231
next →
131
Pain89
Neurology1
Marketed
(probenecid + sulopenem etzadroxil)
Orlynvah ((probenecid [INN] + sulopenem etzadroxil))
Urinary Tract Infections
$ITRMFIterum Therapeutics plc
0 catalysts
Marketed
(prothrombin + (coagulation factor II (human) + coagulation factor VII (human) + coagulation factor IX (human) + coagulation factor X (human) + protein C + protein S)
Balfaxar ((prothrombin + (coagulation factor II (human) + coagulation factor VII (human) + coagulation factor IX (human) + coagulation factor X (human) + protein C + protein S))
Bleeding And Clotting Disorders
Octapharma USA Inc
0 catalysts
Phase 3
(riboflavin + sodium iodide)
(riboflavin [INN] + sodium iodide [USP])
Keratoconus
Epion Therapeutics Inc
0 catalysts
Preclinical
(rifampin + polymyxin B + trimethoprim)
(rifampin + polymyxin B [INN] + trimethoprim)
Bacterial Keratitis
University of Rochester
0 catalysts
Marketed
(sacubitril + valsartan)
Sacubitril + Valsartan ((sacubitril + valsartan))
Cardiovascular Risk Factors
Novugen Pharma (Malaysia) Sdn Bhd
0 catalysts
Phase 2
(segesterone acetate + testosterone)
(segesterone acetate + testosterone [INN])
Male Contraception
Contraline Inc
0 catalysts
Phase 2
(senaparib + temozolomide)
(senaparib [INN] + temozolomide)
Small-Cell Lung Cancer
IMPACT Therapeutics Inc
0 catalysts
Marketed
(sodium benzoate + sodium phenylacetate)
Sodium Benzoate + Sodium Phenylacetate Oceanside ((sodium benzoate + sodium phenylacetate))
Encephalopathy
Oceanside Pharmaceuticals Inc
0 catalysts
Marketed
(sodium nitrite + sodium thiosulfate)
Nithiodote ((sodium nitrite + sodium thiosulfate))
Poisoning
Hope Biosciences LLC
0 catalysts
Phase 2
(sodium phenylbutyrate + taurursodiol)
Unspecified Genetic Disorders
$AMLXAmylyx Pharmaceuticals, Inc.
0 catalysts
Marketed
(sofosbuvir + velpatasvir + voxilaprevir)
Vosevi ((sofosbuvir + velpatasvir + voxilaprevir))
Hepatitis C
$GILDGILEAD SCIENCES, INC.
0 catalysts
Marketed
(sofosbuvir + velpatasvir)
Sofosbuvir + Velpatasvir Asegua ((sofosbuvir + velpatasvir))
Hepatitis C
Asegua Therapeutics LLC
0 catalysts
Marketed
(sulfamethoxazole + trimethoprim)
Sulfamethoxazole + Trimethoprim ((sulfamethoxazole + trimethoprim))
Enteritis
Vista Pharmaceuticals Inc
0 catalysts
Marketed
(tipiracil hydrochloride + trifluridine)
Lonsurf ((tipiracil hydrochloride + trifluridine))
Adenocarcinoma Of The Gastroesophageal Junction
Taiho Oncology Inc
0 catalysts
Preclinical
(tobramycin + vancomycin)
Surgical Wound Infections
Sonoran Biosciences Inc
0 catalysts
Marketed
(trandolapril + verapamil hydrochloride) ER
Trandolapril + Verapamil Hydrochloride ((trandolapril [INN] + verapamil hydrochloride))
Hypertension
Glenmark Pharmaceuticals Ltd
0 catalysts
Marketed
(trospium chloride + xanomeline tartrate)
Cobenfy ((trospium chloride + xanomeline tartrate))
Psychosis
Bristol-Myers Squibb Co
0 catalysts
Marketed
(umeclidinium bromide + vilanterol trifenatate)
Anoro Ellipta ((umeclidinium bromide + vilanterol trifenatate))
Chronic Bronchitis
GlaxoSmithKline LLC
0 catalysts
Preclinical
15d-PMJ2
Colon Cancer
Claradele Pharmaceuticals Inc
0 catalysts
Phase 2
177Lu-LNC-1011
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Yantai Lannacheng Biotechnology Co Ltd
0 catalysts
Preclinical
188-RNLBAM
Hepatocellular Carcinoma
$PSTVPLUS THERAPEUTICS, INC.
0 catalysts
Phase 2
2-DG
Epilepsy
Hexokine Therapeutics Inc
0 catalysts
Phase 1
212Pb-GRPR
Cervical Cancer
Orano Med LLC
0 catalysts
Preclinical
212Pb-LNC-1011
Prostate Cancer
Yantai Lannacheng Biotechnology Co Ltd
0 catalysts
3% SODIUM CHLORIDE
3% SODIUM CHLORIDE (3% SODIUM CHLORIDE)
FRESENIUS KABI USA
0 catalysts
Preclinical
3-HOTP
Obesity
3H Bio Co Ltd
0 catalysts
Preclinical
3D-059
Unspecified Cancer
$SLSSELLAS Life Sciences Group, Inc.
0 catalysts